Nanotechnology-based strategies against SARS-CoV-2 variants
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already infected more
than 500 million people globally (as of May 2022), creating the coronavirus disease 2019 …
than 500 million people globally (as of May 2022), creating the coronavirus disease 2019 …
COVID-19 vaccines: The status and perspectives in delivery points of view
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates
QF Meng, W Tai, M Tian, X Zhuang, Y Pan, J Lai… - Science …, 2023 - science.org
Dexamethasone (DEX) is the first drug to show life-saving efficacy in patients with severe
coronavirus disease 2019 (COVID-19), while DEX is associated with serious adverse …
coronavirus disease 2019 (COVID-19), while DEX is associated with serious adverse …
A materials-science perspective on tackling COVID-19
The ongoing SARS-CoV-2 pandemic highlights the importance of materials science in
providing tools and technologies for antiviral research and treatment development. In this …
providing tools and technologies for antiviral research and treatment development. In this …
The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies
SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still …
Insights from nanotechnology in COVID-19 treatment
In just a few months, SARS-CoV-2 and the disease it causes, COVID-19, created a
worldwide pandemic. Virologists, biologists, pharmacists, materials scientists, and clinicians …
worldwide pandemic. Virologists, biologists, pharmacists, materials scientists, and clinicians …
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
S Yasamineh, HG Kalajahi, P Yasamineh… - Journal of …, 2022 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has
become a pandemic worldwide with mortality of millions. Nanotechnology can be used to …
become a pandemic worldwide with mortality of millions. Nanotechnology can be used to …
Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium
The therapeutic potential of liposomes to deliver drugs into inflamed tissue is well
documented. Liposomes are believed to largely transport drugs into inflamed joints by …
documented. Liposomes are believed to largely transport drugs into inflamed joints by …
Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities
HM Abdel-Mageed, NZ AbuelEzz… - Journal of …, 2021 - Taylor & Francis
The fast progress in nanomedicine and nanoparticles (NP) materials presents
unconventional solutions which are expected to revolutionise health care with great …
unconventional solutions which are expected to revolutionise health care with great …
COVID-19 and corticosteroids: a narrative review
G El-Saber Batiha, AI Al-Gareeb, HM Saad… - …, 2022 - Springer
It has been reported that corticosteroid therapy was effective in the management of severe
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …
acute respiratory syndrome (SARS) and the Middle East Respiratory Syndrome (MERS) …